Literature DB >> 28918442

The role of periostin in lung fibrosis and airway remodeling.

David N O'Dwyer1, Bethany B Moore2,3.   

Abstract

Periostin is a protein that plays a key role in development and repair within the biological matrix of the lung. As a matricellular protein that does not contribute to extracellular matrix structure, periostin interacts with other extracellular matrix proteins to regulate the composition of the matrix in the lung and other organs. In this review, we discuss the studies exploring the role of periostin to date in chronic respiratory diseases, namely asthma and idiopathic pulmonary fibrosis. Asthma is a major health problem globally affecting millions of people worldwide with significant associated morbidity and mortality. Periostin is highly expressed in the lungs of asthmatic patients, contributes to mucus secretion, airway fibrosis and remodeling and is recognized as a biomarker of Th2 high inflammation. Idiopathic pulmonary fibrosis is a fatal interstitial lung disease characterized by progressive aberrant fibrosis of the lung matrix and respiratory failure. It predominantly affects adults over 50 years of age and its incidence is increasing worldwide. Periostin is also highly expressed in the lungs of idiopathic pulmonary fibrosis patients. Serum levels of periostin may predict clinical progression in this disease and periostin promotes myofibroblast differentiation and type 1 collagen production to contribute to aberrant lung fibrosis. Studies to date suggest that periostin is a key player in several pathogenic mechanisms within the lung and may provide us with a useful biomarker of clinical progression in both asthma and idiopathic pulmonary fibrosis.

Entities:  

Keywords:  Asthma; Extracellular matrix; Fibrosis; Matricellular protein; Periostin

Mesh:

Substances:

Year:  2017        PMID: 28918442      PMCID: PMC5659879          DOI: 10.1007/s00018-017-2649-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  101 in total

1.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

2.  Fibrocytes and progression of fibrotic lung disease. Ready for showtime?

Authors:  Bethany B Moore; Martin Kolb
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

Review 3.  Pathobiology of severe asthma.

Authors:  Humberto E Trejo Bittar; Samuel A Yousem; Sally E Wenzel
Journal:  Annu Rev Pathol       Date:  2014-11-24       Impact factor: 23.472

Review 4.  Lebrikizumab for the treatment of asthma.

Authors:  Sabina Antonela Antoniu
Journal:  Expert Opin Investig Drugs       Date:  2016-09-02       Impact factor: 6.206

5.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

6.  Serum periostin relates to type-2 inflammation and lung function in asthma: Data from the large population-based cohort Swedish GA(2)LEN.

Authors:  A James; C Janson; A Malinovschi; C Holweg; K Alving; J Ono; S Ohta; A Ek; R Middelveld; B Dahlén; B Forsberg; K Izuhara; S-E Dahlén
Journal:  Allergy       Date:  2017-05-22       Impact factor: 13.146

7.  Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.

Authors:  Jill E Kolodsick; Marc Peters-Golden; Jose Larios; Galen B Toews; Victor J Thannickal; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05-08       Impact factor: 6.914

8.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals.

Authors:  Go Takayama; Kazuhiko Arima; Taisuke Kanaji; Shuji Toda; Hiroyuki Tanaka; Shunsuke Shoji; Andrew N J McKenzie; Hiroichi Nagai; Takao Hotokebuchi; Kenji Izuhara
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

9.  Neonatal periostin knockout mice are protected from hyperoxia-induced alveolar simplication.

Authors:  Paul D Bozyk; J Kelley Bentley; Antonia P Popova; Anuli C Anyanwu; Marisa D Linn; Adam M Goldsmith; Gloria S Pryhuber; Bethany B Moore; Marc B Hershenson
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts.

Authors:  Kosaku Komiya; Shoichiro Ohta; Kazuhiko Arima; Masahiro Ogawa; Shoichi Suzuki; Yasutaka Mitamura; Satoshi Nunomura; Yasuhiro Nanri; Tomohito Yoshihara; Atsushi Kawaguchi; Jun-Ichi Kadota; Bruce K Rubin; Kenji Izuhara
Journal:  Respir Res       Date:  2017-02-20
View more
  39 in total

1.  Novel Targets for Therapy of Renal Fibrosis.

Authors:  Niki Prakoura; Juliette Hadchouel; Christos Chatziantoniou
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

3.  Apolipoprotein E and Periostin Are Potential Biomarkers of Nasal Mucosal Inflammation. A Parallel Approach of In Vitro and In Vivo Secretomes.

Authors:  Youn Wook Chung; Jimin Cha; Seunghan Han; Yong Chen; Marjan Gucek; Hyung-Ju Cho; Kiichi Nakahira; Augustine M K Choi; Ji-Hwan Ryu; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

4.  Increased concentration of serum periostin is associated with poor outcome of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Weijian Luo; Hao Wang; Jiliang Hu
Journal:  J Clin Lab Anal       Date:  2018-03-02       Impact factor: 2.352

5.  Perivascular macrophages produce type I collagen around cerebral small vessels under prolonged hypertension in rats.

Authors:  Takeshi Inagaki; Ken Fujiwara; Yoshiaki Shinohara; Morio Azuma; Reiji Yamazaki; Kiyomi Mashima; Atsushi Sakamoto; Takashi Yashiro; Nobuhiko Ohno
Journal:  Histochem Cell Biol       Date:  2021-01-04       Impact factor: 4.304

6.  Periostin-modified bone marrow mesenchymal stem cells from osteoporotic rats promote alveolar bone regeneration.

Authors:  Doudou Li; Weiwei Zhou; Meng Cao
Journal:  J Mol Histol       Date:  2019-09-14       Impact factor: 2.611

7.  Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment.

Authors:  Denise E Allard; Yan Wang; Jian Joel Li; Bridget Conley; Erin W Xu; David Sailer; Caellaigh Kimpston; Rebecca Notini; Collin-Jamal Smith; Emel Koseoglu; Joshua Starmer; Xiaopei L Zeng; James F Howard; Ahmet Hoke; Steven S Scherer; Maureen A Su
Journal:  J Clin Invest       Date:  2018-09-17       Impact factor: 14.808

8.  Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.

Authors:  Hiroshige Shimizu; Susumu Sakamoto; Masaki Okamoto; Takuma Isshiki; Junya Ono; Shigeki Shimizu; Tomoaki Hoshino; Kenji Izuhara; Sakae Homma
Journal:  Ann Transl Med       Date:  2021-05

9.  Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases.

Authors:  Cheng-Cheng Deng; Yong-Fei Hu; Ding-Heng Zhu; Qing Cheng; Jing-Jing Gu; Qing-Lan Feng; Li-Xue Zhang; Ying-Ping Xu; Dong Wang; Zhili Rong; Bin Yang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

10.  Identification of Hub Genes Associated with the Pathogenesis of Intracranial Aneurysm via Integrated Bioinformatics Analysis.

Authors:  Aifang Zhong; Ning Ding; Yang Zhou; Guifang Yang; Zhenyu Peng; Hongliang Zhang; Xiangping Chai
Journal:  Int J Gen Med       Date:  2021-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.